Literature DB >> 12851035

Functional characterization of three human cytochrome p450 2E1 variants with amino acid substitutions.

N Hanioka1, T Tanaka-Kagawa, Y Miyata, E Matsushima, Y Makino, A Ohno, R Yoda, H Jinno, M Ando.   

Abstract

1. Cytochrome p450 (p450) 2E1 is a hepatic enzyme of importance for the metabolism of xenobiotics such as drugs and environmental toxicants. Genetic polymorphisms of CYP2E1 in 5'-flanking and coding regions have been found previously in Caucasian and Chinese populations. 2. In order to investigate the effects of amino acid substitutions on the function of CYP2E1, the enzymes of all known CYP2E1 variants in the coding region (CYP2E1.2, CYP2E1.3 and CYP2E1.4) with Arg76His, Val389Ile and Val179Ile substitutions, respectively, as well as the wild-type CYP2E1 (CYP2E1.1) were expressed in COS-1 cells, and their chlorzoxazone 6-hydroxylation and 4-nitrophenol 2-hydroxylation activities were determined. 3. The protein level of CYP2E1.2 was reduced to 29% compared with that of CYP2E1.1. The profiles of the level of activity relative to CYP2E1.1 for chlorzoxazone 6-hydroxylation (300 microM substrate) and 4-nitrophenol 2-hydroxylation (150 microM substrate) were very similar. 4. Although the K(m) values were not significantly different among wild-type and variant CYP2E1s in any oxidation metabolism, the V(max) and V(max)/K(m) of CYP2E1.2 on the basis of the CYP2E1 protein level were 2.7-3.0-fold higher than those of CYP2E1.1. In contrast, the levels of CYP2E1 protein and catalytic activity of CYP2E1.3 and CYP2E1.4 were not affected by the corresponding amino acid substitutions. 5. The findings suggest that Arg76 is closely associated with the function of CYP2E1, and that the genetic polymorphism of CYP2E1 is one cause of interindividual differences in the toxicity of xenobiotics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851035     DOI: 10.1080/0049825031000086400

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  8 in total

1.  Mechanism-based inactivation of human CYP2E1 by diethyldithocarbamate.

Authors:  Matthew Pratt-Hyatt; Hsia-lien Lin; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2010-09-08       Impact factor: 3.922

2.  Associations between CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluric acid/theophylline ratios.

Authors:  Yeomin Yoon; Hyung-Doo Park; Kyoung Un Park; Jin Q Kim; Yoon-Seok Chang; Junghan Song
Journal:  Eur J Clin Pharmacol       Date:  2006-07-14       Impact factor: 2.953

3.  Functional characterization of the chlorzoxazone 6-hydroxylation activity of human cytochrome P450 2E1 allelic variants in Han Chinese.

Authors:  Ting Wang; Huihui Du; Jingsong Ma; Lu Shen; Muyun Wei; Xianglong Zhao; Luan Chen; Mo Li; Guorong Li; Qinghe Xing; Lin He; Shengying Qin
Journal:  PeerJ       Date:  2020-07-31       Impact factor: 2.984

4.  Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population.

Authors:  Ran Huo; Kefu Tang; Zhiyun Wei; Lu Shen; Yuyu Xiong; Xi Wu; Jiamin Niu; Xia Han; Zhengan Tian; Lun Yang; Guoyin Feng; Lin He; Shengying Qin
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

5.  Single-nucleotide polymorphisms and haplotype of CYP2E1 gene associated with systemic lupus erythematosus in Chinese population.

Authors:  Ling-hong Liao; Hao Zhang; Man-Po Lai; Shun-Le Chen; Madeline Wu; Nan Shen
Journal:  Arthritis Res Ther       Date:  2011-01-31       Impact factor: 5.156

6.  Functioning of drug-metabolizing microsomal cytochrome P450s: In silico probing of proteins suggests that the distal heme 'active site' pocket plays a relatively 'passive role' in some enzyme-substrate interactions.

Authors:  Avanthika Venkatachalam; Abhinav Parashar; Kelath Murali Manoj
Journal:  In Silico Pharmacol       Date:  2016-02-19

7.  Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes.

Authors:  Nur Duale; Thomas Bjellaas; Jan Alexander; Georg Becher; Margaretha Haugen; Jan Erik Paulsen; Henrik Frandsen; Pelle Thonning Olesen; Gunnar Brunborg
Journal:  Toxicol Sci       Date:  2009-01-08       Impact factor: 4.849

8.  Functional Characterization of Human CYP2C9 Allelic Variants in COS-7 Cells.

Authors:  Huihui Du; Zhiyun Wei; Yucai Yan; Yuyu Xiong; Xiaoqing Zhang; Lu Shen; Yunfeng Ruan; Xi Wu; Qingqing Xu; Lin He; Shengying Qin
Journal:  Front Pharmacol       Date:  2016-04-25       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.